Organization
Regeneron Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Regeneron Pharmaceuticals, Inc.

... groups. The only heavily Democratic-oriented chief executive from the drug industry was Regeneron’s Leonard Schleifer, who donated $120,000 through the end of August. Express Scripts’ ...
... therefore began with careful profit-taking throughout the third quarter. Some shares of Regeneron and Neurocrine were also sold for tactical reasons. Profits were invested in ...
... CRISPR-mediated, Targeted Gene Insertion Data In a collaboration between Intellia and Regeneron Pharmaceuticals, Inc., researchers combined Intellia's modular lipid nanoparticle (LNP) delivery system of CRISPR/Cas9 ...
... with sites only detected for severe asthma from AstraZeneca and Sanofi / Regeneron. Social media activity is limited to corporate accounts and examples of good ...
... Lilly's Olumiant (baricitinib). Experts this news service interviewed noted lebrikizumab comparisons to Regeneron Pharmaceuticals' Dupixent (dupilumab) boost its chances of achieving a positive outcome or ...
... As the FDA gets set to decide whether Sanofi and Regeneron's atopic dermatitis drug, Dupixent, can make a bid for asthma sales, the ...
... allergies, today announced the initiation of a phase 2 study , with Regeneron and Sanofi, of AR101 with adjunctive dupilumab in peanut-allergic patients. AR101 is ...
... either 1% or 0% for the period. Drugs from Sanofi, GlaxoSmithKline and Regeneron also didn't grow significantly through price hikes, according to the analyst. Alexion's ...
... PR Newswire Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi will present a diverse set of data from ...
Subscribe now for full coverage on Regeneron Pharmaceuticals, Inc.
Start My Free Trial